Russell Investments Group
LUNG icon

Russell Investments Group’s Pulmonx LUNG Stock Holding History

Russell Investments Group’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.21K Buy
4,773
+881
+23% +$1.21K ﹤0.01% 4007
2026
Q1 		$5.02K Sell
3,892
-8,682
-69% -$14.3K ﹤0.01% 3894
2025
Q4 		$27.8K Buy
12,574
+5,567
+79% +$10.5K ﹤0.01% 3507
2025
Q3 		$11.4K Buy
+7,007
New +$14.7K ﹤0.01% 3766
2025
Q1 		– Sell
-20,017
Closed -$136K – 3844
2024
Q4 		$136K Sell
20,017
-16,352
-45% -$108K ﹤0.01% 2626
2024
Q3 		$302K Sell
36,369
-5,750
-14% -$41.6K ﹤0.01% 2404
2024
Q2 		$267K Buy
42,119
+7,172
+21% +$55.1K ﹤0.01% 2402
2024
Q1 		$324K Sell
34,947
-24,361
-41% -$286K ﹤0.01% 2341
2023
Q4 		$756K Sell
59,308
-12,472
-17% -$130K ﹤0.01% 2080
2023
Q3 		$741K Sell
71,780
-37,325
-34% -$432K ﹤0.01% 2068
2023
Q2 		$1.43M Buy
109,105
+18,835
+21% +$230K ﹤0.01% 1742
2023
Q1 		$1.01M Buy
90,270
+26,548
+42% +$262K ﹤0.01% 1961
2022
Q4 		$537K Sell
63,722
-32,528
-34% -$309K ﹤0.01% 2257
2022
Q3 		$1.6M Buy
+96,250
New +$1.77M ﹤0.01% 1674

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Russell Investments Group's LUNG Position: Q2 2026 in Review

Russell Investments Group increased its Pulmonx (LUNG) stake by 23% in Q2 2026, buying an estimated $1.21K and bringing the position to 4,773 shares worth $6.21K. The position accounts for ﹤0.01% of the portfolio, ranked #4007.

Russell Investments Group first reported a position in LUNG in Q3 2022 and has held it in 14 quarters since. The position peaked at $1.6M in Q3 2022. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Russell Investments Group held 4,773 shares of Pulmonx worth $6.21K as of Q2 2026.
  • Russell Investments Group bought 881 Pulmonx shares in Q2 2026, an estimated $1.21K.
  • Pulmonx made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4007 holding.
  • Russell Investments Group first reported a position in Pulmonx in Q3 2022 and has held it in 14 quarters since.
  • Russell Investments Group's Pulmonx position peaked at $1.6M in Q3 2022.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.